vs
Side-by-side financial comparison of Cherry Hill Mortgage Investment Corp (CHMI) and Foghorn Therapeutics Inc. (FHTX). Click either name above to swap in a different company.
Cherry Hill Mortgage Investment Corp is the larger business by last-quarter revenue ($11.8M vs $9.2M, roughly 1.3× Foghorn Therapeutics Inc.). On growth, Foghorn Therapeutics Inc. posted the faster year-over-year revenue change (223.8% vs -37.2%). Over the past eight quarters, Foghorn Therapeutics Inc.'s revenue compounded faster (35.3% CAGR vs -15.2%).
Cherry Hill Mortgage Investment Corp is a U.S.-headquartered real estate finance firm focused on acquiring, investing in and managing residential mortgage-related assets. Its core holdings include agency mortgage-backed securities, residential loans and mortgage servicing rights, operating primarily in the U.S. domestic housing finance market.
Foghorn Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing novel therapies targeting the chromatin regulatory system to treat various types of cancer and other severe diseases. It advances a diverse pipeline of targeted drug candidates, conducting internal R&D and strategic partnerships to serve global patient populations.
CHMI vs FHTX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $11.8M | $9.2M |
| Net Profit | — | $-21.7M |
| Gross Margin | 78.9% | — |
| Operating Margin | 72.1% | -258.2% |
| Net Margin | — | -234.3% |
| Revenue YoY | -37.2% | 223.8% |
| Net Profit YoY | — | -11.1% |
| EPS (diluted) | $0.18 | $-0.35 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $11.8M | $9.2M | ||
| Q3 25 | $8.6M | $8.2M | ||
| Q2 25 | $6.0M | $7.6M | ||
| Q1 25 | $-3.0M | $6.0M | ||
| Q4 24 | $18.7M | $2.9M | ||
| Q3 24 | $-7.1M | $7.8M | ||
| Q2 24 | $6.6M | $6.9M | ||
| Q1 24 | $16.3M | $5.0M |
| Q4 25 | — | $-21.7M | ||
| Q3 25 | $4.5M | $-15.8M | ||
| Q2 25 | $1.6M | $-17.9M | ||
| Q1 25 | $-7.0M | $-18.8M | ||
| Q4 24 | — | $-19.5M | ||
| Q3 24 | $-12.4M | $-19.1M | ||
| Q2 24 | $784.0K | $-23.0M | ||
| Q1 24 | $12.1M | $-25.0M |
| Q4 25 | 78.9% | — | ||
| Q3 25 | 73.2% | — | ||
| Q2 25 | 67.7% | — | ||
| Q1 25 | 183.4% | — | ||
| Q4 24 | 83.3% | — | ||
| Q3 24 | 145.3% | — | ||
| Q2 24 | 47.5% | — | ||
| Q1 24 | 83.9% | — |
| Q4 25 | 72.1% | -258.2% | ||
| Q3 25 | 56.0% | -226.9% | ||
| Q2 25 | 44.4% | -279.2% | ||
| Q1 25 | 223.6% | -385.0% | ||
| Q4 24 | 76.2% | -840.5% | ||
| Q3 24 | 171.8% | -305.5% | ||
| Q2 24 | 22.0% | -386.6% | ||
| Q1 24 | 78.0% | -558.3% |
| Q4 25 | — | -234.3% | ||
| Q3 25 | 52.7% | -194.4% | ||
| Q2 25 | 25.9% | -237.3% | ||
| Q1 25 | 229.2% | -316.4% | ||
| Q4 24 | — | -682.9% | ||
| Q3 24 | 175.8% | -244.9% | ||
| Q2 24 | 11.9% | -333.6% | ||
| Q1 24 | 73.7% | -495.4% |
| Q4 25 | $0.18 | $-0.35 | ||
| Q3 25 | $0.05 | $-0.25 | ||
| Q2 25 | $-0.03 | $-0.28 | ||
| Q1 25 | $-0.29 | $-0.30 | ||
| Q4 24 | $0.30 | $-0.23 | ||
| Q3 24 | $-0.49 | $-0.31 | ||
| Q2 24 | $-0.06 | $-0.45 | ||
| Q1 24 | $0.32 | $-0.59 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $54.9M | $80.9M |
| Total DebtLower is stronger | $146.3M | — |
| Stockholders' EquityBook value | $236.0M | $-108.5M |
| Total Assets | $1.5B | $198.1M |
| Debt / EquityLower = less leverage | 0.62× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $54.9M | $80.9M | ||
| Q3 25 | $55.4M | $89.3M | ||
| Q2 25 | $58.0M | $72.6M | ||
| Q1 25 | $47.3M | $61.0M | ||
| Q4 24 | $46.3M | $55.5M | ||
| Q3 24 | $50.2M | $57.7M | ||
| Q2 24 | $52.4M | $138.9M | ||
| Q1 24 | $47.5M | $79.3M |
| Q4 25 | $146.3M | — | ||
| Q3 25 | $148.0M | — | ||
| Q2 25 | $150.1M | — | ||
| Q1 25 | $150.1M | — | ||
| Q4 24 | $152.1M | — | ||
| Q3 24 | $151.8M | — | ||
| Q2 24 | $160.5M | — | ||
| Q1 24 | $167.5M | — |
| Q4 25 | $236.0M | $-108.5M | ||
| Q3 25 | $233.1M | $-89.7M | ||
| Q2 25 | $229.9M | $-76.7M | ||
| Q1 25 | $226.6M | $-61.7M | ||
| Q4 24 | $230.3M | $-45.5M | ||
| Q3 24 | $236.7M | $-28.3M | ||
| Q2 24 | $234.5M | $-14.3M | ||
| Q1 24 | $247.0M | $-97.5M |
| Q4 25 | $1.5B | $198.1M | ||
| Q3 25 | $1.5B | $205.0M | ||
| Q2 25 | $1.5B | $226.2M | ||
| Q1 25 | $1.4B | $258.7M | ||
| Q4 24 | $1.5B | $284.0M | ||
| Q3 24 | $1.6B | $308.4M | ||
| Q2 24 | $1.4B | $328.6M | ||
| Q1 24 | $1.4B | $255.0M |
| Q4 25 | 0.62× | — | ||
| Q3 25 | 0.63× | — | ||
| Q2 25 | 0.65× | — | ||
| Q1 25 | 0.66× | — | ||
| Q4 24 | 0.66× | — | ||
| Q3 24 | 0.64× | — | ||
| Q2 24 | 0.68× | — | ||
| Q1 24 | 0.68× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $19.1M | $-22.3M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $19.1M | $-22.3M | ||
| Q3 25 | $-2.4M | $-18.9M | ||
| Q2 25 | $12.5M | $-21.0M | ||
| Q1 25 | $682.0K | $-24.0M | ||
| Q4 24 | $-4.7M | $-24.5M | ||
| Q3 24 | $4.4M | $-21.0M | ||
| Q2 24 | $4.1M | $-25.5M | ||
| Q1 24 | $-19.1M | $-29.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $-21.0M | ||
| Q1 25 | — | $-24.0M | ||
| Q4 24 | — | $-25.0M | ||
| Q3 24 | — | $-21.3M | ||
| Q2 24 | — | $-25.6M | ||
| Q1 24 | — | $-29.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -278.2% | ||
| Q1 25 | — | -403.2% | ||
| Q4 24 | — | -875.3% | ||
| Q3 24 | — | -273.0% | ||
| Q2 24 | — | -371.0% | ||
| Q1 24 | — | -583.1% |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.3% | ||
| Q1 25 | — | 0.5% | ||
| Q4 24 | — | 16.8% | ||
| Q3 24 | — | 4.0% | ||
| Q2 24 | — | 0.2% | ||
| Q1 24 | — | 2.0% |
| Q4 25 | — | — | ||
| Q3 25 | -0.53× | — | ||
| Q2 25 | 7.98× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 5.18× | — | ||
| Q1 24 | -1.58× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
